Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LP8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,154
Award facts
- Contract value 100% obligated
- $71,154.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $71,154.18 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 20, 2026. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the headquarters for AmerisourceBergen Drug Corp. This delivery order is a child contract executed under the parent company Cencora, Inc., which does business as AmerisourceBergen and holds the prime indefinite delivery contract with DLA.
This award is issued under Cencora, Inc.'s significant IDC with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. That prime contract vehicle serves as the comprehensive global pharmaceutical support mechanism enabling delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills federal supply requirements through open competition, demonstrating its capability to meet government healthcare needs across multiple therapeutic domains and military treatment facilities.
Quick answers
Who was awarded contract SPE2DR26F9LP8?
SPE2DR26F9LP8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LP8 worth?
The government has obligated $71,154 on SPE2DR26F9LP8.
Is contract SPE2DR26F9LP8 an order under another contract?
Yes. SPE2DR26F9LP8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LP8 competed?
The extent of competition for SPE2DR26F9LP8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award